These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25678176)

  • 41. The dose-dependent effect of chronic administration of haloperidol, risperidone, and quetiapine on sexual behavior in the male rat.
    Zhang XR; Zhang ZJ; Jenkins TA; Cheng WR; Reynolds GP
    J Sex Med; 2011 Dec; 8(12):3345-53. PubMed ID: 20233290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes.
    Mueller C; John C; Perera G; Aarsland D; Ballard C; Stewart R
    Eur J Epidemiol; 2021 Jan; 36(1):89-101. PubMed ID: 32415541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
    Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
    Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone.
    Mintzer JE; Mullen JA; Sweitzer DE
    Curr Med Res Opin; 2004 Sep; 20(9):1483-91. PubMed ID: 15383198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study.
    Langballe EM; Engdahl B; Nordeng H; Ballard C; Aarsland D; Selbæk G
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):321-31. PubMed ID: 24016844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.
    Kinon BJ; Stauffer VL; McGuire HC; Kaiser CJ; Dickson RA; Kennedy JS
    J Am Med Dir Assoc; 2003; 4(4):189-94. PubMed ID: 12837139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimizing atypical antipsychotic treatment strategies in the elderly.
    Katz IR
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S272-7. PubMed ID: 15541168
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A structured trial of risperidone for the treatment of agitation in dementia.
    Lavretsky H; Sultzer D
    Am J Geriatr Psychiatry; 1998; 6(2):127-35. PubMed ID: 9581208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine.
    Nakonezny PA; Byerly MJ; Rush AJ
    J Sex Marital Ther; 2007; 33(3):203-16. PubMed ID: 17454518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
    Potkin SG; Gharabawi GM; Greenspan AJ; Mahmoud R; Kosik-Gonzalez C; Rupnow MF; Bossie CA; Davidson M; Burtea V; Zhu Y; Trivedi JK
    Schizophr Res; 2006 Jul; 85(1-3):254-65. PubMed ID: 16797162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prescribing of antipsychotics in UK primary care: a cohort study.
    Marston L; Nazareth I; Petersen I; Walters K; Osborn DP
    BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discontinuation of antipsychotics treatment for elderly patients within a specialized behavioural unit: a retrospective review.
    Gao RL; Lim KS; Luthra AS
    Int J Clin Pharm; 2021 Feb; 43(1):212-219. PubMed ID: 32909220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and Safety of Risperidone and Quetiapine in Adolescents With Bipolar II Disorder Comorbid With Conduct Disorder.
    Masi G; Milone A; Stawinoga A; Veltri S; Pisano S
    J Clin Psychopharmacol; 2015 Oct; 35(5):587-90. PubMed ID: 26226481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risperidone treatment of behavioral disturbances in outpatients with dementia.
    Irizarry MC; Ghaemi SN; Lee-Cherry ER; Gomez-Isla T; Binetti G; Hyman BT; Growdon JH
    J Neuropsychiatry Clin Neurosci; 1999; 11(3):336-42. PubMed ID: 10440009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission, and Death in Dementia Patients.
    Nerius M; Johnell K; Garcia-Ptacek S; Eriksdotter M; Haenisch B; Doblhammer G
    J Gerontol A Biol Sci Med Sci; 2018 Sep; 73(10):1396-1402. PubMed ID: 29228107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risperidone for the treatment of behavioral disturbances in dementia: a case series.
    Herrmann N; Rivard MF; Flynn M; Ward C; Rabheru K; Campbell B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):220-3. PubMed ID: 9608413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.